NCT06618001
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06618001
Title A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR | ESP | CAN

Facility Status City State Zip Country Details
Arthur J E Child Comprehensive Cancer Centre Calgary Alberta T2N 5G2 Canada Details
Vancouver General Hospital Vancouver British Columbia V5Z 1M9 Canada Details
Princess Margaret Hospital Toronto Ontario M5G 2C1 Canada Details
Hosp Clinic de Barcelona Barcelona 08036 Spain Details
Hosp Univ Fund Jimenez Diaz Madrid 28040 Spain Details
Clinica Univ. de Navarra Pamplona 31008 Spain Details
Addenbrookes Hospital Cambridge Cb2 2qq United Kingdom Details
University College London Hospitals London W1T 7HA United Kingdom Details
The Christie NHS Foundation Trust Christie Hospital Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field